A Phase 2 Single Arm Open-Label Clinical Trial of ADP-A2M4 SPEAR T cells in subjects with Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma (SPEARHEAD 1 STUDY)
Details
Age
Adult
Eligibility
disease must have HLA-A genotype and be MAGE-A4 positive
Type of Study
Treatment
Locations
University of Colorado Hospital
Principal Investigator
Breelyn Wilky, MD
Study ID
Protocol Number: 19-0967
More information available at ClinicalTrials.gov: NCT04044768
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers